These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2478982)

  • 41. Amiloride. Antiarrhythmic and electrophysiologic actions in patients with inducible sustained ventricular tachycardia.
    Duff HJ; Mitchell LB; Kavanagh KM; Manyari DE; Gillis AM; Wyse DG
    Circulation; 1989 Jun; 79(6):1257-63. PubMed ID: 2720927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Na+ channel blockers vs class III antiarrhythmic drugs in treating sustained ventricular tachycardia: reversing and preventing as different electrophysiological mechanisms.
    Masotti CS; Pierangeli A
    Panminerva Med; 1999 Dec; 41(4):295-306. PubMed ID: 10705709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The antiarrhythmic effects of d-sotalol.
    Schwartz J; Crocker K; Wynn J; Somberg JC
    Am Heart J; 1987 Sep; 114(3):539-44. PubMed ID: 3630894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Etatsizin efficacy in patients with ventricular tachycardias. The results of intracardiac electrophysiological research].
    Malakhov VI; Golitsyn SP; Sokolov SF; Bakalov SA; Levin ER; Mikhaĭlova GA; Krutanov IB
    Ter Arkh; 1991; 63(9):32-8. PubMed ID: 1759218
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paradoxical effects of exercise on the QT interval in patients with polymorphic ventricular tachycardia receiving type Ia antiarrhythmic agents.
    Kadish AH; Weisman HF; Veltri EP; Epstein AE; Slepian MJ; Levine JH
    Circulation; 1990 Jan; 81(1):14-9. PubMed ID: 2297822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: electrophysiologic effects and results of programmed ventricular stimulation.
    Doherty JU; Waxman HL; Kienzle MG; Cassidy DM; Marchlinski FE; Buxton AE; Josephson ME
    J Am Coll Cardiol; 1984 Aug; 4(2):378-81. PubMed ID: 6736479
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Electrophysiologic mechanisms of antiarrhythmic efficacy of a sotalol and class Ia drug combination: elimination of reverse use dependence.
    Lee SD; Newman D; Ham M; Dorian P
    J Am Coll Cardiol; 1997 Jan; 29(1):100-5. PubMed ID: 8996301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
    Waxman HL; Buxton AE; Sadowski LM; Josephson ME
    Circulation; 1983 Jan; 67(1):30-7. PubMed ID: 6847803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictive value of electrophysiologic studies during treatment of ventricular tachycardia with the beta-blocking agent nadolol. The Working Group on Arrhythmias of the French Society of Cardiology.
    Leclercq JF; Leenhardt A; Lemarec H; Clémenty J; Hermida JS; Sebag C; Aliot E
    J Am Coll Cardiol; 1990 Aug; 16(2):413-7. PubMed ID: 2373820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Electrocardiographic correlates of spontaneous termination of ventricular tachycardia in patients with coronary artery disease.
    Duff HJ; Mitchell LB; Gillis AM; Sheldon RS; Chudleigh L; Cassidy P; Chiamvimonvat N; Wyse DG
    Circulation; 1993 Sep; 88(3):1054-62. PubMed ID: 8353867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia.
    Miura DS; Schwartz J; Laux B; Wynn J; Keefe D; Somberg JC
    J Clin Pharmacol; 1987 Jul; 27(7):481-6. PubMed ID: 3654999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
    Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM
    Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute effects of combination of IB and IC antiarrhythmics for the treatment of ventricular tachycardia.
    Bleske BE; Kluger J; Fisher J; Chow MS
    J Clin Pharmacol; 1989 Nov; 29(11):998-1002. PubMed ID: 2513339
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electrophysiologic and clinical factors influencing response to class IA antiarrhythmic agents in patients with inducible sustained monomorphic ventricular tachycardia.
    Gold RL; Haffajee CI; Alpert JS
    Am Heart J; 1986 Jul; 112(1):9-13. PubMed ID: 3728294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The clinical electrophysiology of intravenous indecainide.
    Horowitz LN; Spielman SR; Webb CR; Morganroth J; Greenspan AM
    Am Heart J; 1985 Oct; 110(4):784-8. PubMed ID: 4050649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of intravenous and oral nadolol for supraventricular tachycardia in children.
    Mehta AV; Chidambaram B
    J Am Coll Cardiol; 1992 Mar; 19(3):630-5. PubMed ID: 1538020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of type I antiarrhythmic drugs on the signal-averaged electrocardiogram in patients with malignant ventricular arrhythmias.
    Greenspon AJ; Kidwell GA; DeCaro M; Hessen S
    Pacing Clin Electrophysiol; 1992 Oct; 15(10 Pt 1):1445-53. PubMed ID: 1383955
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction, and ventricular tachycardia induction.
    Kułakowski P; Karczmarewicz S; Karpiński G; Soszyńska M; Ceremuzyński L
    Europace; 2000 Jul; 2(3):207-15. PubMed ID: 11227590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia.
    Wyndham CR; Pratt CM; Mann DE; Winkle RA; Somberg J; de Maria AN; Josephson ME
    Am J Cardiol; 1987 Oct; 60(11):67F-72F. PubMed ID: 3310588
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation.
    Kim SG; Felder SD; Waspe LE; Fisher JD
    Am J Cardiol; 1986 Sep; 58(6):485-90. PubMed ID: 3529910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.